Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs

Artificial Organs

Volumn 29, Issue 1, 2005, Pages 83-87

  Kono, Tetsuya ^a   Hanazaki, Kazuhiro ^a   Yazawa, Kazuyuki ^a   Ashizawa, Satoshi ^a   Fisher, William E ^a   Wang, Xiao Ping ^a   Nosé, Yukihiko ^a   Brunicardi, F Charles ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Artificial pancreas; Pancreatic polypeptide; Total pancreatectomy

Indexed keywords

ARTIFICIAL ORGANS; BLOOD; GLUCOSE;

ARTIFICIAL PANCREAS; BLOOD GLUCOSE; BLOOD GLUCOSE LEVEL; IN-VIVO; INSULIN INFUSIONS; MECHANICAL DEVICE; NORMOGLYCEMIA; PANCREATIC POLYPEPTIDES; SECOND GROUP; TOTAL PANCREATECTOMY;

INSULIN;

INSULIN; PANCREAS POLYPEPTIDE; ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL PANCREAS; CONTROLLED STUDY; DISEASE MODEL; DOG; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESPONSE; MALE; NONHUMAN; PANCREAS RESECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; ANIMAL; INSULIN INFUSION;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; BLOOD GLUCOSE; DOGS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MODELS, ANIMAL; PANCREATECTOMY; PANCREATIC POLYPEPTIDE;

EID: 21444447444     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.29008.x     Document Type: Article

References (21)

1. Slezak LA, Anderson DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001;25:452-60.
2. Seymour NE, Brunicardi FC, Chaiken RL, et al. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 1988;104:119-29.
3. Sun YS, Brunicardi FC, Druck P, et al. Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 1986;151:130-40.
4. Shichiri M, Kawamori R, Goriya Y, et al. Long-term application of wearable artificial endocrine pancreas close-loop intravenous vs subcutaneous insulin infusion. Life Support Syst 1985;3(Suppl 1):583-7.
5. Emoto M, Nishizawa Maekawa K, et al. Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy. Metabolism 1997;46:1013-8.
6. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-94. Diabetes Care 1998;21: 518-24.
7. Orci L, Baetens D, Rawazzola M, et al. Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 1976;19:1811-16.
8. Anderson DK, Brunicardi FC. Pancreatic anatomy and physiology. In: Greenfield L, ed. Surgery: Scientific Principles and Practice. Philadelphia, PA: Lippincott, 1993;775-91.
9. Brunicardi FC, Sun YS, Druck P, et al. Splanchnic neural regulation of insulin and glucagon secretion in the isolated perfused human pancreas. Am J Surg 1987;153:34-40.
10. Brunicardi FC, Druck P, Sun YS, et al. Regulation of pancreatic polypeptide secretion in the isolated perfused human pancreas. Am J Surg 1988;155:63-9.
11. + channels in islets transplanted into diabetic mice. Diabetes 1996;45:1755-60.
12. Soria B, Andreu E, Berna G, et al. Engineering pancreatic islet. Pflugers Arch 2000;440:1-18.
13. Albisse AM, Leibel BS, Ewart TG, et al. An artificial endocrine pancreas. Diabetes 1974;23:389-96.
14. Albisser AM, Leibel BS, Ewart TG, et al. Clinical control of diabetes by the artificial pancreas. Diabetes 1974;23:397-404.
15. Malaisse-Lagae F, Stefan Y, Cox J, et al. Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 1979;17:361-5.
16. Brunicardi F, Dyen Y, Brostrom L, et al. The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolated perfused human pancreas. Pancreas 2000;21:203-11.
17. Glaser B, Zoghlin G, Pienta K, et al. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 1988;20:288-92.
18. Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996;81:3566-72.
19. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human diseases. Diabetes 1988;37:1595-607.
20. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
21. Hanazaki K, Nosé Y, Brunicardi F. Artificial endocrine pancreas. J Am Coll Surg 2001;193:310-22.